The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes a lot of our portfolios are looking rather sad at the moment, but the number of negative posts recently has surprised me. If you're in this for LT then these kind of SP fluctuations don't matter in the slightest.
Yes there is shorting going on, and day traders popping in - but so what.
Let them short it down and then trade it back up, it's all just noise. The fun of an AIM share :-D
Earlier this year Gerry and Ross scooped up a handful of shares each at 83p and 89p
- I'm inclined to take that as a Bullish long term signal!
I remember DebC a short while ago getting in a negative place after the AGM and SP decline...
...and then a few days later posting an apology to GB on twitter as the SP began to recover a bit.
(which was a lovely exchange I thought).
It's easy to see the negatives when we're in the red, and forget how AWESOME (yes muggins) the fundamentals are.
It's just a temporary low - we'll soon see a lovely bounce from Chesh's double wobbly bottom, the rampygram will go out,
and the board will be filled with live commentary on share price fluctuations and we'll be on the top risers before you know it.
Look at Novacyt - it was 20p in Jan, rose to £1.66 by Feb - but then dropped to 65p, climbed to £4.91 in April -
to be at £2.15 in June....its last close was £8.40! Thats a massive rise in 10 mths - but there
were some hefty dips along the way.
So with all this negativity going on, I thought I'd type out a few of my thoughts on why I love this company!
So, Lab grown skin has been in development for years - and it's an area i've been interested in because of the
implications for ending animal testing. Without lab grown skin companies would be testing their products on
animals, usually rabbits. Which as a bunny owner just horrifies me.
Most major cosmetics companies have discontinued animal testing unless it’s required by law. Which unfortunately is
still the case in China. Encouragingly though, China has recently lifted import restrictions on products with
alternative safety assessments, and is looking to reform its regulatory framework and establish alternatives.
This is a huge step forward in phasing out animal testing in china, and Deepverges Labskin is ideally placed to become
a key part of the new regulatory environment emerging.
There are various lab grown skins out there, MatTeks Epiderm and Loreals Episkin probably being the biggest ones.
They use the skin to test their own products, as well as selling it to cosmetics, pharmaceutical, chemical
and household product manufacturers that conduct similar tests and the global scientific community to support
academic and corporate research and development activities.
Companies are however trying to develop more cost-effective methods, both as an alternative to animal testing and as a prior screening to their clinical work.